SHFH · XBRL financial data
Scientist Home Future Health financial statements, every quarter
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (SHFH's year ends in late December)
| In thousands of dollars | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 45 | 32 | 40 | 88* | 189 | 84* | 212 |
| Revenue from contracts with customers | 45 | 32 | — | year only | 182 | 83 | 212 |
| Cost of revenue | 25 | 18 | 24 | 55* | 130 | 55 | 91 |
| Cost of goods and services sold | 0 | 0 | 0 | 1* | 0 | 0 | 0 |
| Gross profit | 20 | 14 | 16 | 33* | 59 | 29 | 121 |
| Selling, general and administrative | 13 | 52 | 64 | 185* | 161 | 127 | 113 |
| Total operating expenses | (13) | 77* | 64* | (442)* | (161) | (127)* | (113)* |
| Operating income (loss) | 7 | (38) | (48) | (153)* | (102) | (98) | 8 |
| Income tax expense (benefit) | (1) | (1) | 0 | 0* | 0 | 0 | 0 |
| Net income (loss) | 6 | (37) | (48) | (153)* | (102) | (98) | 8 |
| Earnings per share, diluted USD per share | 0.00 | 0.00 | 0.00 | (0.01)* | 0.00 | 0.00 | 0.00 |
| Weighted average shares, diluted thousands of shares | 23,480 | 23,501 | 23,661 | 23,717* | 23,716 | 23,716 | 23,716 |
Balance sheet
CSVFiscal quarters (SHFH's year ends in late December)
| In thousands of dollars | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 16 | 111 | 276 | 69 | 15 | 9 | 14 |
| Inventory | 3 | 3 | 2 | 34 | 31 | 34 | 129 |
| Prepaid and other current assets | — | — | — | 89 | — | 82 | 83 |
| Total current assets | 20 | 115 | 326 | 192 | 132 | 125 | 226 |
| Property and equipment, net | — | 0 | — | 73 | 69 | 65 | 61 |
| Right-of-use asset | — | — | 397 | 379 | 358 | 339 | 320 |
| Total assets | 20 | 115 | 723 | 644 | 559 | 530 | 608 |
| Accrued liabilities | — | 4 | 4 | 24 | 21 | 32 | 29 |
| Total current liabilities | 20 | 63 | 123 | 214 | 252 | 340 | 424 |
| Total deposits | — | — | — | 48 | — | — | 50 |
| Lease liability, non-current | — | — | 333 | 317 | 295 | 276 | 262 |
| Total liabilities | 20 | 63 | 456 | 531 | 547 | 616 | 686 |
| Accumulated deficit | (9) | (46) | (94) | (247) | (349) | (447) | (438) |
| Total stockholders' equity | 0 | 52 | 267 | 113 | 11 | (86) | (78) |
| Total liabilities and equity | 20 | 115 | 723 | 644 | 559 | 530 | 608 |
| Common shares outstanding (cover page) thousands of shares | 23,480 | 23,544 | 23,716 | 23,716 | 23,716 | 23,716 | 23,716 |
Cash flows
CSVFiscal quarters (SHFH's year ends in late December)
| In thousands of dollars | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|
| Net income (loss) | 6 | (37) | (48) | (153)* | (102) | (98) | 8 |
| Net cash from operating activities | (5) | (5)* | (99)* | (139)* | (72) | (13)* | (45)* |
| Purchases of property and equipment | — | — | — | year only | — | — | — |
| Net cash from investing activities | — | — | — | year only | — | — | — |
| Proceeds from issuing common stock | — | — | 266* | 0* | — | — | 0* |
| Net cash from financing activities | 2 | 101* | 265* | 8* | 19 | 7* | 49* |
| Net change in cash | (2) | 95* | 164* | — | (54) | (6)* | 5* |
Compare with peers
SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Scientist Home Future Health | 14 | 212 | (45)* | 23.7M | — | 10-QSep 30, 2026 |
| Karbon-X | 335 | 344 | (1,198) | 109.2M | — | 10-Q/AAug 31, 2026 |
| Longevity Health Holdings | 35 | 396 | (224)* | 2.5M | 0.2 quarters | 10-QJun 30, 2026 |
| DSwiss | 258 | 512 | 50* | 206.9M | — | 10-QJun 30, 2026 |
| Bonk | 214 | 793 | (2,226)* | 8.0M | 0.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.